Financials data is unavailable for this security.
View more
Year on year Viemed Healthcare Inc grew revenues 31.82% from 138.83m to 183.01m. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 64.63% net income growth from 6.22m to 10.24m.
| Gross margin | 60.28% |
|---|---|
| Net profit margin | 4.88% |
| Operating margin | 7.81% |
| Return on assets | 6.56% |
|---|---|
| Return on equity | 8.92% |
| Return on investment | 8.40% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Viemed Healthcare Inc fell by 4.08m. However, the company earned 45.21m from its operations for a Cash Flow Margin of 24.70%. In addition the company generated 2.83m cash from financing while 52.11m was spent on investing.
| Cash flow per share | 0.8747 |
|---|---|
| Price/Cash flow per share | 9.95 |
| Book value per share | 3.21 |
|---|---|
| Tangible book value per share | 2.34 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.31 |
|---|---|
| Quick ratio | 1.19 |
| Total debt/total equity | 0.0522 |
|---|---|
| Total debt/total capital | 0.0489 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 62.30%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 1.15 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 12.29 |
